Cited by 42Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismCardiovascular Disease and Adiposity

Inflammation and the depot-specific secretome of human preadipocytes

Open access
Zhu, Yi, Tchkonia, Tamara, Stout, Michael B., Giorgadze, Nino, Wang, Libing, Li, Peter W., Heppelmann, Carrie J., Bouloumié, Anne +3 more·2015·Obesity

Abstract

OBJECTIVE: Visceral white adipose tissue (WAT) expansion and macrophage accumulation are associated with metabolic dysfunction. Visceral WAT typically shows greater macrophage infiltration. Preadipocytes show varying proinflammatory expression profiles among WAT depots. The objective was to examine the secretomes and chemoattractive properties of preadipocytes from visceral and subcutaneous WAT. METHODS: A label-free quantitative proteomics approach was applied to study secretomes of subcutaneous and omental preadipocytes from obese subjects. Enzyme-linked immunosorbent assays and chemotaxis assays were used to confirm proinflammatory chemokine secretion between depots. RESULTS: Preadipocyte secretomes showed greater variation between depots than did intracellular protein expression. Chemokines were the most differentially secreted proteins. Omental preadipocytes induced chemoattraction of macrophages and monocytes. Neutralizing antibodies to the identified chemokines reduced macrophage/monocyte chemoattraction. Subcutaneous preadipocytes treated with interleukin-6 (IL-6) resembled omental preadipocytes in terms of chemokine secretion and macrophage/monocyte chemoattraction. Janus-activated kinase (JAK1/2) protein expression, which transduces IL-6 signaling, was higher in omental than subcutaneous preadipocytes and WAT. Inhibiting JAK in omental preadipocytes decreased chemokine secretion and macrophage/monocyte chemoattraction to levels closer to that observed in subcutaneous preadipocytes. CONCLUSIONS: Secretomes of omental and subcutaneous preadipocytes are distinct, with the former inducing more macrophage/monocyte chemoattraction, in part through IL-6/JAK-mediated signaling.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/oby.21053

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Natural flavonoids such as quercetin and fisetin, used alone or with dasatinib, can promote senolysis in multiple in vitro and in vivo settings.

    “The use of various natural flavonoids, including quercetin and fisetin, either alone or in combination with dasatinib, a pan-tyrosine kinase inhibitor, can stimulate senolysis in a variety of contexts in vitro and in vivo199,207–210.”

    From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [207]

    The Results section on JAK inhibition reports changes in chemokine secretion and monocyte attraction by human preadipocytes, not senolysis. Searches for quercetin, fisetin, dasatinib, and senolytic effects found no passage addressing flavonoid-induced senolysis in vitro or in vivo; page numbers were unavailable in our copy. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhu, Y., Tchkonia, T., Stout, M. B., Giorgadze, N., Wang, L., Li, P. W., Heppelmann, C. J., Bouloumié, A., Jensen, M. D., Bergen, H. R., & Kirkland, J. L.
Affiliations
  • Mayo Clinic (US)
  • Robert and Arlene Kogod Center on Aging; Mayo Clinic; Rochester Minnesota USA
  • Université Toulouse III - Paul Sabatier (FR)
Corresponding author
Kirkland, James L.
Venue
Obesity
Publisher
Wiley
Published
2015-04-10
Volume
23
Issue
5
Pages
989-999
ISSN
1930-7381 (ISSN-L)
OpenAlex
W1514732199
Cited by
42
References
40
Citations by year
2026: 2 · 2025: 3 · 2024: 5 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 6 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 5 · 2015: 3
FWCI
4.70
Type
journal article
Language
en
Open access
Locations
  • Obesity (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (AG31736, AG13925, AG41122, DK50456, DK40484)
  • Ellison Foundation
  • Inserm
  • Noaber Foundation
  • Ted Nash Foundation
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
preadipocytes, secretome, visceral adipose tissue, subcutaneous adipose tissue, omental adipose tissue, chemokines, monocytes, interleukin-6, adipose tissue inflammation
MeSH terms
Enzyme-Linked Immunosorbent Assay, Humans, Inflammation, Macrophages, Monocytes, Obesity, Omentum, Proteins, Interleukin-6, Subcutaneous Fat, Intra-Abdominal Fat, Adipocytes, White

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review